Modera Wealth Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Modera Wealth Management’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,805	Closed	-$40.6K	–	654
2024 Q3	$40.6K	Buy	10,805 +9,471	+710%	+$54.4K	﹤0.01%	603
2024 Q2	$12.7K	Buy	1,334 +103	+8%	+$3.47K	﹤0.01%	572
2024 Q1	$93.2K	Buy	1,231 +686	+126%	+$90.5K	﹤0.01%	563
2023 Q4	$96.9K	Buy	545 +226	+71%	+$111K	﹤0.01%	515
2023 Q3	$225K	Buy	319 +92	+41%	+$394K	﹤0.01%	497
2023 Q2	$1.04M	Hold	227	–	–	0.02%	291
2023 Q1	$602K	Hold	227	–	–	0.02%	198
2022 Q4	$592K	Buy	+227	New	+$792K	0.02%	192

Other funds holding SEEL

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

VWWMG

Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return

Modera Wealth Management's SEEL Position: Q4 2024 in Review

Modera Wealth Management sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2024, closing a stake of 10,805 shares — an estimated $40.6K sold.

Modera Wealth Management first reported a position in SEEL in Q4 2022 and held it in 8 quarters. The position peaked at $1.04M in Q2 2023. 2 funds tracked by Wall St. Rank hold SEEL as of Q4 2024.

Modera Wealth Management reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Modera Wealth Management sold 10,805 Seelos Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $40.6K.
Modera Wealth Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q4 2022 and held it in 8 quarters.
Modera Wealth Management's Seelos Therapeutics, Inc. Common Stock position peaked at $1.04M in Q2 2023.
2 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Modera Wealth Management's 13F filing for Q4 2024, filed 6 Feb 2025.